PIK3CB and cancer: Figure 5A,B demonstrated that pathways involving proteoglycans in cancer, PI3K‐Akt signaling pathway, regulation of actin cytoskeleton, TGF‐beta signaling pathway and transcriptional mis‐regulation in cancer had greater enrichment in the low‐risk group.